vadimezan has been researched along with Cancer of Head in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, G; Zhang, C; Zhang, J | 1 |
| Folaron, M; Frangou, C; Hicks, WL; Kalmuk, J; Kuriakose, MA; Lockwood, J; Merzianu, M; Rigual, NR; Seshadri, M; Singh, AK; Sullivan-Nasca, M; Turowski, SG; Vokes, J | 1 |
| Coulthard, T; Sacadura, NT; Seshadri, M | 1 |
| Bellnier, DA; Bhattacharya, A; Mazurchuk, R; Rustum, YM; Seshadri, M; Spernyak, JA | 1 |
4 other study(ies) available for vadimezan and Cancer of Head
| Article | Year |
|---|---|
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Interferons; Lapatinib; Male; Membrane Proteins; Mice, Inbred BALB C; Nucleotides, Cyclic; Pyridines; Receptor, ErbB-2; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor Receptor-2; Xanthones; Xenograft Model Antitumor Assays | 2021 |
Vascular priming enhances chemotherapeutic efficacy against head and neck cancer.
Topics: Antineoplastic Agents; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Microscopy, Fluorescence; Xanthones; Xenograft Model Antitumor Assays | 2013 |
Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging.
Topics: Animals; Area Under Curve; Carcinoma, Squamous Cell; Female; Gadolinium; Head and Neck Neoplasms; Humans; Magnetic Resonance Angiography; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds; Transplantation, Heterologous; Ultrasonography; Xanthones | 2011 |
Activity of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid against human head and neck carcinoma xenografts.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Xanthones | 2006 |